围绕「人参皂甙」与「修护」，本页收录 8 篇公开发表的学术文献（2017–2023 年）：5 篇给出支持性数据，3 篇仅涉及作用机制，其中 1 篇为人体临床研究。以上为各原研究作者的结论，本平台不作再评价。
归类针对的是「单篇文献对某一项具体指标是否给出支持性数据」，不是对本成分的评价；结论均为原研究作者观点。
Review reports positive effects in AD patients (lower EASI, TEWL, IgE) and in vivo models (decreased TEWL, IgE, cytokines).
Review reports positive effects in AD patients (lower EASI, TEWL, IgE) and in vivo models (decreased TEWL, IgE, cytokines).
GS ameliorated UVB-induced epidermal barrier dysfunction, restored FLG, IVL, Cldn-1, AQP3 levels, and inhibited MAPK phosphorylation in mice and HaCaT cells.
GS ameliorated UVB-induced epidermal barrier dysfunction, restored FLG, IVL, Cldn-1, AQP3 levels, and inhibited MAPK phosphorylation in mice and HaCaT cells.
CK restored TEWL, hydration, epidermal hyperplasia, and SPINK5 expression in both models, improving skin barrier function.
CK restored TEWL, hydration, epidermal hyperplasia, and SPINK5 expression in both models, improving skin barrier function.
Rh2 alleviated AD-like skin symptoms, suppressed immune cell infiltration, cytokine expression, and IgE levels in mice; inhibited TSLP via NF-κB.
Rh2 alleviated AD-like skin symptoms, suppressed immune cell infiltration, cytokine expression, and IgE levels in mice; inhibited TSLP via NF-κB.
KRG reduced clinical severity, ear thickness, TEWL, scratching, IgE, IL-31, and Th2 inflammation in mice.
KRG reduced clinical severity, ear thickness, TEWL, scratching, IgE, IL-31, and Th2 inflammation in mice.
Study focuses on formulation to enhance skin deposition of 20S-PPD; no direct efficacy measurement on skin repair.
Study focuses on formulation to enhance skin deposition of 20S-PPD; no direct efficacy measurement on skin repair.
Study focuses on formulation to enhance skin deposition of PPD; no direct efficacy measurement on skin repair.
Study focuses on formulation to enhance skin deposition of PPD; no direct efficacy measurement on skin repair.
Review describes anti-aging mechanisms (immune, anti-melanin, anti-oxidation, collagen/hyaluronic acid) but no original experimental data.
Review describes anti-aging mechanisms (immune, anti-melanin, anti-oxidation, collagen/hyaluronic acid) but no original experimental data.
篇数为本站收录的公开文献数，不同功效之间不可直接比较强弱 —— 研究热度受行业投入影响，与成分实际表现无关。
排序依据是本站收录的公开文献篇数，只反映研究数量、不代表功效强弱，也不是选料建议。
本站收录 8 篇与「修护」相关的公开发表研究，年份跨度 2017–2023；其中人体临床研究 1 篇。逐篇的研究类型与结论解读见本页「文献逐条」。
不能。中国现行法规要求功效宣称依据按《化妆品功效宣称评价规范》以人体功效评价试验、消费者使用测试或实验室试验等规定方式取得，文献综述仅在特定情形下可用。本页只是公开文献的整理，不构成宣称依据。
按原研究作者自身的结论归类：支持 5 篇、结论不一 0 篇、未观察到效果或结论相反 0 篇、仅机制探讨 3 篇。本站收录到的这些研究结论方向一致，但样本量与试验条件各不相同。
国家药监局备案数据中，含人参皂甙且宣称「修护」的产品有 174 个，占该成分全部备案产品的 12.88%，相对全市场的富集度 lift 为 4.401。共现是市场统计上的相关性，不代表该成分对该功效有贡献。
是否收录于《已使用化妆品原料目录》、以及各法域的限量与使用范围，见人参皂甙的成分档案页；本页只整理与「修护」相关的文献证据，不含法规限值。